Technimark will create 80 new roles over the next two years as it expands its operations in Longford, with a 50,000-square-foot addition, doubling the size of its existing plant.
Technimark will be investing €26 million to expand the facility's capacity in medical manufacturing, including precision injection moulding, value-added assembly, finished device assembly and contract manufacturing.
The project is supported by the Irish Government through IDA Ireland.
Taoiseach Micheál Martin said: "It is a great pleasure to visit Technimark in Longford today as they announce a major investment and the creation of up to 80 jobs. This is an important day for Technimark, Longford and the wider region, and testament to the continued attractiveness of Ireland as a place where businesses of all sizes can flourish and thrive.”
Kris Peavy, chief commercial officer and president of healthcare, said: “A key component in our organic growth strategy is ensuring we have state-of-the-art cleanroom facilities and open capacity to support our customers' current and future manufacturing needs. Our many expansions around the globe underpin that strategy."
In addition to Ireland’s expansion, Technimark recently acquired a 204,000-square-foot medical facility adjacent to its U.S. headquarters and has expansions underway at facilities in the United Kingdom, Germany and China to support growth in the medical market.
Brad Wellington, chief executive officer, added: “Technimark is committed to growing our business in Ireland and we are extremely excited to have this new space available for our global medical customer base. Ireland is seeing pronounced growth in the medtech market, and our facility is ideally located to serve our customers in the region.”
In addition to increased manufacturing space the expansion will include Technimark’s first European Innovation Centre. The centre will incorporate office space to house designers and engineers as well as a complete production lab to perform prototype manufacturing.
